Effect of methotrexate and 5-fluorouracil on de novo thymidilate synthesis in human colon carcinoma cell line, Caco-2

Journal of Nutritional Biochemistry

Volumn 7, Issue 9, 1996, Pages 513-517

  Choi, Sang Woon ^a   Shane, Barry ^b   Selhub, Jacob ^a  

^a TUFTS UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

5 FU; Caco 2; colon cancer; deoxyuridine suppression test; methotrexate; thymidylate synthesis; 3H deoxyuridine incorporation into DNA

Indexed keywords

FLUOROURACIL; METHOTREXATE; THYMIDINE PHOSPHATE;

ARTICLE; CELL CULTURE; CELL LINE; COLON CARCINOMA; CONTROLLED STUDY; DNA SYNTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY;

EID: 0030250526     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/0955-2863(96)00103-9     Document Type: Article

References (29)

1. 1 Bresalier, R.S. and Kim, Y.S. (1993). Malignant neoplasms of the large intestine. In Gastrointestinal Disease (M.H. Sleisenger and J.S. Fordtran, eds.), pp. 1449-1493, WB Saunders, Philadelphia, PA USA
2. 2 Levin, B. (1991). Approach to therapy of large bowel cancer. In The large intestine (S.F. Phillips, J.H. Pemberton, and R.G. Shorter, eds.), pp. 687-695, Raven Press, New York, NY USA
3. 3 Mayer, R.J. (1991). Systemic therapy for colorectal cancer: an overview. Semin. Oncol. 18, 62-66
4. 4 Mayer, R.J. (1992). Chemotherapy for metastatic colorectal cancer. Cancer 70 (Suppl), 1414-1424
5. 5 Kemeny, N. (1994). Current approaches to metastatic colorectal cancer. Semin. Oncol. 21 (Suppl 7), 67-75
6. 6 Bedikian, A.Y., Valdivieso, M., Mavligit, G.M., Burgess, M.A., Rodriguez, V., and Bodey, G.P. (1978). Sequential chemotherapy of colorectal cancer. Cancer 42, 2169-2176
7. 7 Isacoff, W.H., Eilber, F., Tabbarah, H., Klein, P., Dollinger, M., Lemkin, S., Sheehy, P., Cone, L., Rosenbloom, B., Sieger, L., and Block, J.B. (1978). Phase 2 clinical trial with high-dose methotrexate therapy and citroforum factor rescue. Cancer Treat. Rep. 62, 1295-1304
8. 8 Marsh, J.C., Bertino, J.R., Katz, K.H., Davis, C.A., Durivage, H.J., Rome, L.S., Richards, F., Capizzi, R.L., Farber, L.R., Pasquale, D.N., Stuart, R., Koletsky, A.J., Makuch, R., and O'Hollaren, K. (1991). The influence of drug interval on the effect of methotrexate and fluorouracil in the treatment of advanced colorectal cancer. J. Clin. Oncol. 9, 371-380
9. 9 Kemeny, N., Lokich, J.J., Anderson, N., and Ahlgren, J.D. (1993). Recent advances in the treatment of advanced colorectal cancer. Cancer 71, 9-18
10. 10 Schornagel, J.H. and McVie, J.G. (1983). The clinical pharmacology of methotrexate. Cancer Treat. Rev. 10, 53-75
11. 11 Jukes, T.H. (1987). Searching for magic bullets: early approaches to chemotherapy antifolates, methotrexate-the Bruce F. Cain memorial award lecture. Cancer Res. 7, 5528-5536
12. 12 Jansen, G., Westerhof, G.R., Kathmann, I., Rademarker, B.C., Rijksen, G., and Schornagel, J.H. (1989). Identification of a membrane-associated folate-binding protein in human leukemic CCRF-CEM cells with transport-related methotrexate resistance. Cancer Res. 49, 2455-2459
13. 13 Cowan, K.H. and Jolivet, J. (1984). A methotrexate-resistant human breast cancer cell line with multiple defects, including diminished formation of methotrexate polyglutamates. J. Biol. Chem. 259, 10793-10800
14. 14 Li, W.W., Lin, J.T., Tong, W.P. Trippett, T.M., Brennan, M.F., and Bertino, J.R. (1992). Mechanism of natural resistance to antifolates in human soft tissue sarcomas. Cancer Res. 52, 1434-1438
15. 15 Cravo M.L., Mason, J.B., Selhub, J., and Rosenberg, I.H. (1991). Use of the deoxyuridine suppression test to evaluate localized folate deficiency in rat colonic epithelium. Am. J. Clin. Nutr. 53, 1450-1454
16. 16 Pelliniemi, T.T. and Beck, W.S. (1980). Biochemical mechanism in the Killmann experiment. J. Clin. Invest. 65, 449-460
17. 17 Hidalgo, I.J., Raub, T.J., and Borchardt, R.T. (1989). Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology 96, 736-749
18. 18 Grasset, E., Pinto, M., Dussaulx, E., Zweibaum, A., and Desjeux, J. (1984). Epithelial property of human colonic carcinoma cell line Caco-2: electrical parameters. Am. J. Physiol. 247, C260-C267
19. 19 Hidalgo, I.J., Kato, A., and Borchardt, R.T. (1989). Binding of epidermal growth factor by human colon carcinoma cell (Caco-2) monolayers. Biochem. Biophy. Res. Comm. 160, 317-324
20. 3 in Caco-2 cells. Arch. Biochem. Biophy. 308, 171-174
21. 21 Hall, T.C. (1962). A comparative study of 5-fluorouracil (FU), 5-fluorodeoxyuridine (FUDR), and methotrexate (MTX)-Progress report. Cancer Chemo. Rep. 16, 391-396
22. 22 Advanced colorectal cancer meta-analysis project. (1994). Meta-analysis of randomized trial testing the biochemical modulation of fluorouracil by methotrexate in metastatic colorectal cancer. J. Clin. Oncol. .12, 960-969
23. 23 Rodenhuis, S., McGuire, J.J., Narayanan, R., and Bertino, J.R. (1986). Development of an assay system for the detection and classification of methotrexate resistance in fresh human leukemic cells. Cancer Res. 46, 6513-6519
24. 24 Grem, J.L., Voeller, D.M., Geoffroy, F., Horak, E., Johnston, P.G., and Allegra, C.J. (1994). Determinants of trimetrexate lethality in human colon cancer cells. Br. J Cancer 70, 1075-1084
25. 25 Selhub, J., Dhar, J., and Rosenberg, I.H. (1986). Gastrointestinal absorption of folates and antifolates. In Membrane Transport of Antineoplastic Agents (I.D. Goldman, ed.), pp. 147-168, Pergamon Press, Oxford UK
26. 26 Zimmerman, J. (1992). Methotrexate transport in the human intestine. Biochem. Pharm. 43, 2377-2383
27. 27 Zimmerman, J. (1992). Drug interactions in intestinal transport of folic acid and methotrexate. Biochem. Pharm. 44, 1839-1842
28. 28 Grem, J.L. (1990). Fluorinated pyrimidines. In Cancer Chemotherapy (B.A. Chabner and J.M. Collins, eds.), pp. 180-224, J.B. Lippincott Company, Philadelphia, PA USA
29. 29 Pinedo, H.M. and Peters, G.F. (1988). Fluorouracil: Biochemistry and pharmacology. J. Clin. Oncol. 6, 1653-1664